EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter trial of amlodipine in children with hypertension



Multicenter trial of amlodipine in children with hypertension



Pediatric Research 51(4 Part 2): 430A-431A, April




(PDF 0-2 workdays service: $29.90)

Accession: 035349958

Download citation: RISBibTeXText



Related references

Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Clinical Therapeutics 29(9): 1924-1936, 2007

Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial. Clinical Therapeutics 34(9): 1940-1947, 2013

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial. Clinical Therapeutics 28(4): 537-551, 2006

Multicenter community-based trial of Amlodipine in hypertension. Harefuah 137(3-4): 89-92, 1999

Multicenter community-based trial of amlodipine in hypertension in Israel. Harefuah 137(3-4): 89-93, 176, 2000

Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension. Clinical Therapeutics 27(4): 441-450, 2005

Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial. Clinical Therapeutics 30(5): 845-857, 2008

A multicenter single-blind trial evaluating the efficacy of amlodipine in patients with severe hypertension. American Journal of Hypertension 14(4 Part 2): 109A-110A, April, 2001

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study. Drug Design, Development and Therapy 10(): 3817-3826, 2016

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial. Annals of PharmacoTherapy 42(11): 1552-1562, 2008

The amlodipine cardiovascular community trial A prospective, large-scale multicenter study in a diverse population of patients with mild to moderate hypertension. Journal of the American Society of Nephrology 5(3): 563, 1994

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study. Bmc Research Notes 4(): 461-461, 2011

An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Clinical Therapeutics 30(9): 1618-1628, 2008

Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Journal of the Association of Physicians of India 52(): 197-202, 2005